Stock Price
14.04
Daily Change
0.06 0.43%
Monthly
-4.10%
Yearly
6.85%
Q1 Forecast
13.57



Peers Price Chg Day Year Date
Anglo-eastern Plants 1,640.00 -50.00 -2.96% 121.02% Mar/26
Beiersdorf 75.22 0.26 0.35% -37.24% Mar/26
Jumbo 22.80 0.62 2.80% -12.24% Mar/26
Fourlis 4.45 0.11 2.54% 8.41% Mar/26
Ontex 4.09 0.03 0.62% -52.44% Mar/26
L'Oréal 350.85 -1.15 -0.33% 2.59% Mar/26
Reckitt Benckiser 5,074.00 -30.00 -0.59% -1.63% Mar/26
Sarantis 14.04 0.06 0.43% 6.85% Mar/26
Unilever 4,485.00 -38.50 -0.85% -0.73% Mar/26

Indexes Price Day Year Date
Athens General 2060 2.14 0.10% 17.98% Mar/26

Sarantis traded at 14.04 this Thursday March 26th, increasing 0.06 or 0.43 percent since the previous trading session. Looking back, over the last four weeks, Sarantis gained 4.10 percent. Over the last 12 months, its price rose by 6.85 percent. Looking ahead, we forecast Sarantis to be priced at 13.57 by the end of this quarter and at 12.14 in one year, according to Trading Economics global macro models projections and analysts expectations.

Gr Sarantis SA is a Greece-based company active in the manufacture and distribution of consumer products. Its product portfolio includes Fragrances and Cosmetics, like aftershave lotions and deodorants with brands such as Adidas and C-THRU; household products, like food packaging, cleaning and shoe care products of such brands as Sanitas and Camel and health and care products, which mainly comprise vitamins and food supplements. The Company has also formed joint-ventures and strategic alliances with international companies in the cosmetics, health and beauty sectors, such as Estee Lauder, Kolastyna, Domet, Topstar and Clinique, for exclusive distribution of their products in Greece and Eastern Europe. The Company’s subsidiaries include SARANTIS PORTUGAL, ASTRID S.R.O. and Polipak Sp. z.o.o.